BELLMAWR, New Jersey (WPVI) -- A young South Jersey boy has one wish for his birthday this year, and that is to help raise money for those living with a rare disease. Nine-year-old AJ Gonzales of ...
The Food and Drug Administration approved Sohonos, Ipsen Pharmaceuticals’ ultra-rare bone disease drug, Wednesday evening. The drug capsules are approved with an indication as a retinoid for reducing ...
PARIS, FRANCE, 16 August 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today approval by the U.S. Food and Drug Administration (FDA) of Sohonos™ (palovarotene) capsules as a retinoid indicated ...
Fibrodysplasia Ossificans Progressiva: Symptoms, Complications and Diagnosis: By Shreoshree Chakrabarty There are distinct reasons for the unique characteristics of muscle and bone. Muscle provides ...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Phase 2 results from the PROGRESS study evaluating zilurgisertib, an investigational ALK2 inhibitor, ...
Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026 - Late-breaking rapid-fire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results